MAPT and tauopathy: Overall, we have shown that RI‐AG03 is stable and capable of entering cells, crossing the Drosophila blood‐brain barrier to reduce aggregation of Tau in cells and in vivo and significantly suppress aggregation‐dependent phenotypes including neurodegeneration and shortened lifespan in a Drosophila model of Tauopathy.